These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26241420)

  • 1. Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial.
    D'Anna R; Di Benedetto A; Scilipoti A; Santamaria A; Interdonato ML; Petrella E; Neri I; Pintaudi B; Corrado F; Facchinetti F
    Obstet Gynecol; 2015 Aug; 126(2):310-315. PubMed ID: 26241420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial.
    Santamaria A; Di Benedetto A; Petrella E; Pintaudi B; Corrado F; D'Anna R; Neri I; Facchinetti F
    J Matern Fetal Neonatal Med; 2016 Oct; 29(19):3234-7. PubMed ID: 26698911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial.
    Asimakopoulos G; Pergialiotis V; Anastasiou E; Antsaklis P; Theodora M; Vogiatzi E; Kallergi A; Sindos M; Loutradis D; Daskalakis G
    Trials; 2020 Jul; 21(1):633. PubMed ID: 32646482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial.
    Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C
    J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial.
    Asimakopoulos G; Pergialiotis V; Antsaklis P; Theodora M; Loutradis D; Daskalakis G
    Arch Gynecol Obstet; 2024 Oct; 310(4):1895-1903. PubMed ID: 39141124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial.
    Celentano C; Matarrelli B; Pavone G; Vitacolonna E; Mattei PA; Berghella V; Liberati M
    J Matern Fetal Neonatal Med; 2020 Mar; 33(5):743-751. PubMed ID: 30558466
    [No Abstract]   [Full Text] [Related]  

  • 7. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Vitagliano A; Saccone G; Cosmi E; Visentin S; Dessole F; Ambrosini G; Berghella V
    Arch Gynecol Obstet; 2019 Jan; 299(1):55-68. PubMed ID: 30564926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of myo-inositol on glucose variability in women with gestational diabetes.
    Pintaudi B; Di Vieste G; Corrado F; Lucisano G; Giunta L; D'Anna R; Di Benedetto A
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6567-6572. PubMed ID: 30338829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.
    Fraticelli F; Celentano C; Zecca IA; Di Vieste G; Pintaudi B; Liberati M; Franzago M; Di Nicola M; Vitacolonna E
    Acta Diabetol; 2018 Aug; 55(8):805-812. PubMed ID: 29774465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study.
    D'Anna R; Scilipoti A; Giordano D; Caruso C; Cannata ML; Interdonato ML; Corrado F; Di Benedetto A
    Diabetes Care; 2013 Apr; 36(4):854-7. PubMed ID: 23340885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis.
    Factor PA; Corpuz H
    J ASEAN Fed Endocr Soc; 2023; 38(2):102-112. PubMed ID: 38045667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
    Santamaria A; Alibrandi A; Di Benedetto A; Pintaudi B; Corrado F; Facchinetti F; D'Anna R
    Am J Obstet Gynecol; 2018 Sep; 219(3):300.e1-300.e6. PubMed ID: 29859136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and acceptability of
    Amaefule CE; Drymoussi Z; Dodds J; Sweeney L; Pizzo E; Daru J; Robson J; Poston L; Khalil A; Myers J; Harden A; Hitman GA; Khan K; Zamora J; Huda MSB; Thangaratinam S
    BMJ Open; 2018 Sep; 8(9):e022831. PubMed ID: 30249632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial.
    Farren M; Daly N; McKeating A; Kinsley B; Turner MJ; Daly S
    Diabetes Care; 2017 Jun; 40(6):759-763. PubMed ID: 28325784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial.
    Vitale SG; Corrado F; Caruso S; Di Benedetto A; Giunta L; Cianci A; D'Anna R
    Int J Food Sci Nutr; 2021 Aug; 72(5):670-679. PubMed ID: 33238798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial.
    Esmaeilzadeh S; Ghadimi R; Mashayekh-Amiri S; Delavar MA; Basirat Z
    Minerva Obstet Gynecol; 2023 Aug; 75(4):357-364. PubMed ID: 35686634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review.
    D'Anna R; Santamaria A; Alibrandi A; Corrado F; DI Benedetto A; Facchinetti F
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S59-S61. PubMed ID: 31619648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study.
    Amaefule CE; Drymoussi Z; Gonzalez Carreras FJ; Pardo Llorente MDC; Lanz D; Dodds J; Sweeney L; Pizzo E; Thomas A; Heighway J; Daru J; Sobhy S; Poston L; Khalil A; Myers J; Harden A; Hitman G; Khan KS; Zamora J; Pérez T; Huda MSB; Thangaratinam S
    BMJ Open; 2022 Mar; 12(3):e050110. PubMed ID: 35277398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
    Guo X; Guo S; Miao Z; Li Z; Zhang H
    J Diabetes Complications; 2018 Mar; 32(3):342-348. PubMed ID: 29325728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myo-inositol supplementation for prevention of gestational diabetes mellitus in overweight and obese pregnant women: a systematic review and meta-analysis.
    Mashayekh-Amiri S; Mohammad-Alizadeh-Charandabi S; Abdolalipour S; Mirghafourvand M
    Diabetol Metab Syndr; 2022 Jul; 14(1):93. PubMed ID: 35794663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.